K2M Group Holdings Inc. (KTWO) 22.96 $KTWO
K2M Announces Enhanced Complex Spine Portfolio With Addition of Its Innovative NILE(TM) Alternative Fixation Spinal System
GlobeNewswire - Wed Mar 25, 8:25AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the NILE(TM) Alternative Fixation Spinal System, the Company's latest offering for addressing the most complex spinal deformity cases. K2M also received a CE Mark for NILE, which allows the Company to expand the global availability of the product.
KTWO: 22.96 (-0.47)
K2M Group Is Packed With Catalysts For 2015
Dallas Salazar - at Seeking Alpha - Fri Mar 20, 4:24PM CDT
KTWO: 22.96 (-0.47)
Freeport-McMoRan and Guess are big market movers
AP - Thu Mar 19, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
VTSS: 5.27 (-0.01), RTRX: 24.45 (+0.09), MSCC: 35.98 (-0.16), KTWO: 22.96 (-0.47), FOLD: 11.97 (-0.35), NKTR: 10.90 (+0.16), ADBE: 75.50 (+0.88)
Correction: Earns-K2M Group story
AP - Thu Mar 19, 2:53PM CDT
LEESBURG, Va. (AP) — In a March 18 story about K2M Group earnings, The Associated Press erroneously reported that the company had a full-year profit. It had a loss for the year.
KTWO: 22.96 (-0.47)
K2M Group Holdings' (KTWO) CEO Eric Major on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 18, 9:39PM CDT
KTWO: 22.96 (-0.47)
K2M Group beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 3:13PM CDT
KTWO: 22.96 (-0.47)
K2M Group Holdings Inc. Reports 2014 Revenue Growth of 18.5% Fourth Quarter and Full Year 2014 Financial Results; Fourth Quarter Complex Spine Growth of 20.5% Year-over-Year
GlobeNewswire - Wed Mar 18, 3:05PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M", a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today reported financial results for the fourth quarter and fiscal year ended December 31, 2014.
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Closes Sale Pursuant to Over-Allotment Option
GlobeNewswire - Thu Feb 12, 3:01PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company", a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the closing of the sale of 906,748 shares of common stock by certain of the selling stockholders in the Company's follow-on offering pursuant to the underwriters' option to purchase additional shares, at a price of $18.75 per share before underwriting discounts. K2M did not receive any proceeds from the sale of these shares.
KTWO: 22.96 (-0.47)
InsiderInsights.com Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK
InsiderInsights - at Seeking Alpha - Wed Feb 11, 3:29AM CST
ZIOP: 10.88 (+0.03), TROV: 8.58 (-0.27), CRR: 33.68 (-0.12), SLG: 128.51 (+0.39), WMS: 28.56 (+0.53), MLNK: 3.75 (unch), RXN: 26.33 (+0.16), KTWO: 22.96 (-0.47), PANW: 153.87 (-0.50), YHOO: 43.97 (-0.52), WHR: 191.77 (-2.20), UA: 82.27 (-1.25), GILD: 104.18 (-1.02), R: 97.95 (+1.15), SIX: 49.97 (+1.37), DATA: 98.72 (-0.13), TW: 130.02 (+0.52), MA: 91.20 (+3.43), NVET: 8.61 (-0.27), IPGP: 97.60 (+1.46)
4 Big-Volume Stocks to Trade for Breakouts: TrueBlue, K2M and More
at The Street - Mon Feb 09, 12:33PM CST
These stocks rising on unusual volume are within range of triggering breakout trades.
TBI: 25.87 (+0.44), ANIP: 69.79 (+1.24), SBGI: 31.39 (+0.30), KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Closes Follow-On Offering
GlobeNewswire - Fri Feb 06, 3:05PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company", a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the closing of a follow-on offering of 6,044,990 shares of its common stock at a price of $18.75 per share. K2M sold 2,044,990 shares of common stock in the offering and selling stockholders named in the registration statement sold 4,000,000 shares of common stock in the offering. In addition, certain of the selling stockholders have granted the underwriters a 30-day option from the date of the prospectus to purchase up to 906,748 additional shares of common stock at the public offering price, less underwriting discounts.
KTWO: 22.96 (-0.47)
Update: K2M Group's Secondary Offering
Dallas Salazar - at Seeking Alpha - Wed Feb 04, 7:01AM CST
KTWO: 22.96 (-0.47)
Nasdaq stocks posting largest volume increases
AP - Tue Feb 03, 5:44PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HIHO: 3.29 (+0.09), GTWN: 18.07 (-0.02), ONTX: 2.48 (-0.05), JAXB: 11.33 (+0.15), KTWO: 22.96 (-0.47), MTSL: 1.73 (-0.12), HTWO: 9.70 (-0.11), OBAS: 7.04 (-0.29), GPIC: 12.71 (+0.74), SSYS: 53.60 (+0.17), WAYN: 13.28 (-0.08), ADVS: 43.69 (-0.11)
K2M prices equity offering
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 8:47AM CST
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Announces Pricing of Follow-On Offering
GlobeNewswire - Tue Feb 03, 7:42AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company", a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the pricing of a follow-on offering of 6,044,990 shares of its common stock at a price of $18.75 per share. K2M is selling 2,044,990 shares of common stock in the offering and selling stockholders named in the registration statement are selling 4,000,000 shares of common stock in the offering. In addition, certain of the selling stockholders have granted the underwriters a 30-day option from the date of the prospectus to purchase up to 906,748 additional shares of common stock at the public offering price, less underwriting discounts.
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Commences Follow-on Offering
GlobeNewswire - Thu Jan 29, 6:43AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company" a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the commencement of a follow-on public offering of its common stock. The Company expects to raise approximately $40 million and selling stockholders named in the registration statement expect to sell approximately 4,906,748 shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters.
KTWO: 22.96 (-0.47)
K2M spinal screw system cleared by FDA
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 11:10AM CST
KTWO: 22.96 (-0.47)
K2M Receives FDA 510(k) Clearance for the Next Generation of Its Innovative Complex Spine MESA(R) Technology
GlobeNewswire - Wed Jan 21, 10:54AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M", a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MESA 2 Deformity Spinal System. MESA 2 is the Company's next-generation pedicle screw system designed to address the most complex spinal pathologies.
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Files Registration Statement for Follow-on Offering
GlobeNewswire - Tue Jan 20, 8:32AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company" a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC" relating to a proposed follow-on public offering of its common stock. The Company expects to raise approximately $40 million and selling stockholders named in the registration statement expect to sell approximately 4.9 million shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters.
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2014 Financial Results, Including Q4 US Complex Spine Growth of 20%
GlobeNewswire - Mon Jan 12, 4:00PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) today reported certain preliminary financial results for the three months and twelve months ending December 31, 2014.
KTWO: 22.96 (-0.47)
K2M Announces Enhanced Complex Spine Portfolio With Addition of Its Innovative NILE(TM) Alternative Fixation Spinal System
GlobeNewswire - Wed Mar 25, 8:25AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the NILE(TM) Alternative Fixation Spinal System, the Company's latest offering for addressing the most complex spinal deformity cases. K2M also received a CE Mark for NILE, which allows the Company to expand the global availability of the product. KTWO: 22.96 (-0.47)
K2M Group Is Packed With Catalysts For 2015
Dallas Salazar - at Seeking Alpha - Fri Mar 20, 4:24PM CDT
KTWO: 22.96 (-0.47)
Freeport-McMoRan and Guess are big market movers
AP - Thu Mar 19, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
VTSS: 5.27 (-0.01), RTRX: 24.45 (+0.09), MSCC: 35.98 (-0.16), KTWO: 22.96 (-0.47), FOLD: 11.97 (-0.35), NKTR: 10.90 (+0.16), ADBE: 75.50 (+0.88)
Correction: Earns-K2M Group story
AP - Thu Mar 19, 2:53PM CDT
LEESBURG, Va. (AP) — In a March 18 story about K2M Group earnings, The Associated Press erroneously reported that the company had a full-year profit. It had a loss for the year.
KTWO: 22.96 (-0.47)
K2M Group Holdings' (KTWO) CEO Eric Major on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 18, 9:39PM CDT
KTWO: 22.96 (-0.47)
K2M Group beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 3:13PM CDT
KTWO: 22.96 (-0.47)
K2M Group Holdings Inc. Reports 2014 Revenue Growth of 18.5% Fourth Quarter and Full Year 2014 Financial Results; Fourth Quarter Complex Spine Growth of 20.5% Year-over-Year
GlobeNewswire - Wed Mar 18, 3:05PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today reported financial results for the fourth quarter and fiscal year ended December 31, 2014. KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Closes Sale Pursuant to Over-Allotment Option
GlobeNewswire - Thu Feb 12, 3:01PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the closing of the sale of 906,748 shares of common stock by certain of the selling stockholders in the Company's follow-on offering pursuant to the underwriters' option to purchase additional shares, at a price of $18.75 per share before underwriting discounts. K2M did not receive any proceeds from the sale of these shares. KTWO: 22.96 (-0.47)
InsiderInsights.com Daily Round Up 2/10/15: ZIOP, WMS, R, MLNK
InsiderInsights - at Seeking Alpha - Wed Feb 11, 3:29AM CST
ZIOP: 10.88 (+0.03), TROV: 8.58 (-0.27), CRR: 33.68 (-0.12), SLG: 128.51 (+0.39), WMS: 28.56 (+0.53), MLNK: 3.75 (unch), RXN: 26.33 (+0.16), KTWO: 22.96 (-0.47), PANW: 153.87 (-0.50), YHOO: 43.97 (-0.52), WHR: 191.77 (-2.20), UA: 82.27 (-1.25), GILD: 104.18 (-1.02), R: 97.95 (+1.15), SIX: 49.97 (+1.37), DATA: 98.72 (-0.13), TW: 130.02 (+0.52), MA: 91.20 (+3.43), NVET: 8.61 (-0.27), IPGP: 97.60 (+1.46)
4 Big-Volume Stocks to Trade for Breakouts: TrueBlue, K2M and More
at The Street - Mon Feb 09, 12:33PM CST
These stocks rising on unusual volume are within range of triggering breakout trades.
TBI: 25.87 (+0.44), ANIP: 69.79 (+1.24), SBGI: 31.39 (+0.30), KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Closes Follow-On Offering
GlobeNewswire - Fri Feb 06, 3:05PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the closing of a follow-on offering of 6,044,990 shares of its common stock at a price of $18.75 per share. K2M sold 2,044,990 shares of common stock in the offering and selling stockholders named in the registration statement sold 4,000,000 shares of common stock in the offering. In addition, certain of the selling stockholders have granted the underwriters a 30-day option from the date of the prospectus to purchase up to 906,748 additional shares of common stock at the public offering price, less underwriting discounts. KTWO: 22.96 (-0.47)
Update: K2M Group's Secondary Offering
Dallas Salazar - at Seeking Alpha - Wed Feb 04, 7:01AM CST
KTWO: 22.96 (-0.47)
Nasdaq stocks posting largest volume increases
AP - Tue Feb 03, 5:44PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HIHO: 3.29 (+0.09), GTWN: 18.07 (-0.02), ONTX: 2.48 (-0.05), JAXB: 11.33 (+0.15), KTWO: 22.96 (-0.47), MTSL: 1.73 (-0.12), HTWO: 9.70 (-0.11), OBAS: 7.04 (-0.29), GPIC: 12.71 (+0.74), SSYS: 53.60 (+0.17), WAYN: 13.28 (-0.08), ADVS: 43.69 (-0.11)
K2M prices equity offering
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 8:47AM CST
KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Announces Pricing of Follow-On Offering
GlobeNewswire - Tue Feb 03, 7:42AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the pricing of a follow-on offering of 6,044,990 shares of its common stock at a price of $18.75 per share. K2M is selling 2,044,990 shares of common stock in the offering and selling stockholders named in the registration statement are selling 4,000,000 shares of common stock in the offering. In addition, certain of the selling stockholders have granted the underwriters a 30-day option from the date of the prospectus to purchase up to 906,748 additional shares of common stock at the public offering price, less underwriting discounts. KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Commences Follow-on Offering
GlobeNewswire - Thu Jan 29, 6:43AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced the commencement of a follow-on public offering of its common stock. The Company expects to raise approximately $40 million and selling stockholders named in the registration statement expect to sell approximately 4,906,748 shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters. KTWO: 22.96 (-0.47)
K2M spinal screw system cleared by FDA
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 11:10AM CST
KTWO: 22.96 (-0.47)
K2M Receives FDA 510(k) Clearance for the Next Generation of Its Innovative Complex Spine MESA(R) Technology
GlobeNewswire - Wed Jan 21, 10:54AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MESA 2 Deformity Spinal System. MESA 2 is the Company's next-generation pedicle screw system designed to address the most complex spinal pathologies. KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Files Registration Statement for Follow-on Offering
GlobeNewswire - Tue Jan 20, 8:32AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC" relating to a proposed follow-on public offering of its common stock. The Company expects to raise approximately $40 million and selling stockholders named in the registration statement expect to sell approximately 4.9 million shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters. KTWO: 22.96 (-0.47)
K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2014 Financial Results, Including Q4 US Complex Spine Growth of 20%
GlobeNewswire - Mon Jan 12, 4:00PM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) today reported certain preliminary financial results for the three months and twelve months ending December 31, 2014.
KTWO: 22.96 (-0.47)
